NATIONAL BANK OF CANADA /FI/

Bank

Position in BIO — Bio-Rad Laboratories, Inc.

CIK 926171 MONTREAL, A8

Position in BIO

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$19,084,650

-$6,002,850 QoQ

Shares Held

65,000

-27.8% QoQ

Ownership

0.243%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NATIONAL BANK OF CANADA /FI/ holds $605,387,760 across 43 Medical Devices names. BIO ranks #9 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	458,110	$144,231,349
2	ABT	Abbott Laboratories	1,315,185	$119,339,884
3	MDT	Medtronic plc	1,095,014	$85,662,943
4	DXCM	Dexcom Inc	1,065,517	$71,762,568
5	BSX	Boston Scientific Corp	958,975	$40,929,051
6	NEOG	Neogen Corp	4,000,000	$35,960,000
7	EW	Edwards Lifesciences Corp	357,656	$32,353,559
8	ZBH	Zimmer Biomet Holdings, Inc.	229,490	$19,756,793

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,084,650	65,000	-27.8%	Shares	Defined	2026-08-10
2026-03-31	$25,087,500	90,000	+1534.0%	Shares	Defined	2026-05-15
2024-06-30	$1,504,289	5,508	+19.1%	Shares	Defined	2024-08-02
2024-03-31	$1,598,956	4,623	-70.6%	Shares	Defined	2024-05-13
2023-12-31	$5,080,349	15,734	-13.2%	Shares	Defined	2024-02-06
2023-09-30	$6,499,055	18,131	+5.1%	Shares	Defined	2023-10-10
2023-06-30	$6,538,681	17,247	+1059.9%	Shares	Defined	2023-07-26
2023-03-31	$712,302	1,487	+138.3%	Shares	Defined	2023-04-12
2022-12-31	$262,384	624	-56.0%	Shares	Defined	2023-01-24
2022-09-30	$591,504	1,418	-6.6%	Shares	Defined	2022-10-13
2022-06-30	$751,410	1,518	-81.0%	Shares	Defined	2022-07-28
2022-03-31	$4,510,909	8,009	-27.8%	Shares	Defined	2022-05-05
2021-12-31	$8,378,515	11,089	—	Shares	Defined	2022-01-24
No filing history on record for this holder in this stock.